Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Microbial Stereoselective Hydrolysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN87100031A reveals microbial hydrolysis for high-purity S-Naproxen. Enables cost reduction in pharmaceutical intermediate manufacturing and supply chain reliability.